The effect of phosphatidylserine administration on memory and symptoms of attention-deficit hyperactivity disorder: a randomised, double-blind, placebo-controlled clinical trial.

@article{Hirayama2014TheEO,
  title={The effect of phosphatidylserine administration on memory and symptoms of attention-deficit hyperactivity disorder: a randomised, double-blind, placebo-controlled clinical trial.},
  author={Sho Hirayama and Katsutoshi Terasawa and Roland Rabeler and Takehisa Hirayama and Takeshi Inoue and Yoshiki Tatsumi and Martin Purpura and Ralf J{\"a}ger},
  journal={Journal of human nutrition and dietetics : the official journal of the British Dietetic Association},
  year={2014},
  volume={27 Suppl 2},
  pages={284-91}
}
BACKGROUND Attention-deficit hyperactivity disorder (ADHD) is the most commonly diagnosed behavioural disorder of childhood, affecting 3-5% of school-age children. The present study investigated whether the supplementation of soy-derived phosphatidylserine (PS), a naturally occurring phospholipid, improves ADHD symptoms in children. METHODS Thirty six children, aged 4-14 years, who had not previously received any drug treatment related to ADHD, received placebo (n = 17) or 200 mg day(-1) PS… CONTINUE READING